Adjust Font Sizing:

Industry News

Recent News:

 

February 21, 2024—Narcolepsy Network would like to share a press release that is posted on Harmony Biosciences’ website. This press release indicates Food & Drug Administration grants priority review to Harmony Biosciences’ application for WAKIX® (pitolisant) in pediatric narcolepsy.

October 17, 2023—Narcolepsy Network would like to share recent news from Neurology Live regarding recent findings from Harmony Biosciences’ Phase 3 INTUNE Study Evaluating Pitolisant in Patients with Idiopathic Hypersomnia.

September 7, 2023—Narcolepsy Network would like to share a press release that is posted on Harmony Biosciences’ website. This press release indicates Food & Drug Administration orphan drug designation for pitolisant for treatment of idiopathic hypersomnia.

February 15, 2024—Narcolepsy Network would like to share an update from Takeda Pharmaceuticals regarding its intention to rapidly initiate the first Global Phase 3 Trials of TAK-861, an Oral Orexin Agonist, in Narcolepsy Type 1 in First Half of Fiscal Year 2024.

March 30, 2023—Narcolepsy Network would like to share a press release that is posted on Jazz Pharmaceuticals’ website. This press release indicates that Jazz Pharmaceuticals is expanding support of the American Heart Association to raise awareness of the link between sleep disorders and heart health.